Nasus Pharma Stock Reiterated at Market Outperform by Citizens
Citizens JMP reiterates Nasus Pharma as Market Outperform, highlighting the company's innovative nasal spray technology and promising pipeline. We analyze the implications for investors.
IRS Mails Saver's Match Notices: What to Know for 2027
The IRS has started sending letters about the Saver's Match, a new retirement benefit starting in 2027 that could put up to $2,000 in eligible savers' pockets. Here's what to expect.
Beckham's £39m Dividend: Inside His World Cup Earnings
David Beckham has taken a £39m dividend from his business empire after a summer of World Cup brand deals drove record profits at his holding company.
East London's New Food Hub Aims to Cut Waste and Feed Thousands
A major new food redistribution warehouse in Barking is set to channel 10 tonnes of surplus food to charities every week, tackling waste and hunger across the capital.
The Future of Retirement? Work Until You Die
Social Security once promised a dignified retirement, but shifting demographics and economic pressures are forcing a reckoning. Explore why working until death may become the new norm and what it means for your future.
Great grid upgrade off track: ministers must reveal bill risks
The UK's £70bn electricity grid overhaul is running over budget and behind schedule, yet ministers remain silent on the impact for household bills. This analysis explores what's going wrong and why transparency is urgently needed.
Heating Oil Prices Surge: Should Families Buy Now or Wait?
Heating oil prices have nearly doubled in a year, leaving families with a tough choice: lock in now or gamble on a price drop.
Tim Cook's $47M Apple Exit: Inside the Executive Chair Pay Deal
Tim Cook's transition to executive chair comes with a $47 million compensation package, nearly matching incoming CEO John Ternus's award. Here's what the deal signals for Apple's governance and future.
